New phloroglucinol compound and applications of new phloroglucinol compound in preparation of antibacterial drugs
A technology of phloroglucinol and antibacterial drugs, which is applied in the field of natural medicines and chemical drugs, can solve the problems of in-depth research, and achieve the effects of low eukaryotic cell toxicity, significant antibacterial activity, and strong activity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Extraction, separation and structural identification of the compound of Example 1
[0031] (1) Take 8 kg of dried myrtle branches and leaves, pulverize them into coarse powder, extract 4 times by percolation with 95% (w / w) ethanol, each 25 L, combine the percolation liquid and concentrate under reduced pressure to no alcohol smell, The obtained total extract is about 1.2kg. The extract was suspended with water and then extracted with petroleum ether to obtain 389 g of petroleum ether extraction fractions.
[0032] (2) Carry out silica gel column chromatography on the petroleum ether extraction part prepared in step (1), using petroleum ether-ethyl acetate as eluent, according to the volume ratio of petroleum ether and ethyl acetate is 100:0, 100:1 , 100:3, 100:5, 100:7, 100:10, 100:30, 100:50, 100:100 and 0:100 elution gradients were eluted, analyzed by thin layer chromatography (TLC) and combined Similar fractions were obtained to obtain 10 main fractions Fr.1-Fr.10....
Embodiment 2
[0048] Example 2 Inhibitory effect of (+) Myrtucyclitones A-B and (-) Myrtucyclitones A-B on various bacteria
[0049] Staphylococcus aureus S.aureus ATCC29213, Methicillin-resistant Staphylococcus aureus S.aureus ATCC33591(MRSA), Vancomycin-intermediate-resistant Staphylococcus aureus S.aureus Mu50(VISA), Staphylococcus epidermidis S.epidermidis ATCC12228 , Enterococcus faecalis ATCC29212, Enterococcus faecalis E.faecium 13-01, Escherichia coli E.coli ATCC25922, Pseudomonas aeruginosa Ps.Aeruginosa, all from the Institute of Medical Biotechnology, Chinese Academy of Medical Sciences.
[0050] The minimum inhibitory concentration (MIC) of the compound in vitro was determined by the broth micro-dilution method. The specific operation method is as follows:
[0051] (1) Bacterial culture: The experimental bacteria were cultured in Mueller-Hinton (MH) broth medium, and when they grew for 8-12 h to a concentration of about 0.5 Mcfarland (1×10 8 CFU).
[0052] (2) The test sample ...
Embodiment 3
[0058] Example 3 Effects of (+) Myrtucyclitones A-B and (-) Myrtucyclitones A-B on normal cells
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com